James Lu
Cited by
Cited by
p-Multigrid solution of high-order discontinuous Galerkin discretizations of the compressible Navier–Stokes equations
KJ Fidkowski, TA Oliver, J Lu, DL Darmofal
Journal of Computational Physics 207 (1), 92-113, 2005
Controlled vocabularies and semantics in systems biology
M Courtot, N Juty, C Knüpfer, D Waltemath, A Zhukova, A Dräger, ...
Molecular systems biology 7 (1), 543, 2011
Inverse problems in systems biology
HW Engl, C Flamm, P Kügler, J Lu, S Müller, P Schuster
Inverse Problems 25 (12), 123014, 2009
An implicit, exact dual adjoint solution method for turbulent flows on unstructured grids
EJ Nielsen, J Lu, MA Park, DL Darmofal
Computers & Fluids 33 (9), 1131-1155, 2004
The SBML ODE Solver Library: a native API for symbolic and fast numerical analysis of reaction networks
R Machné, A Finney, S Müller, J Lu, S Widder, C Flamm
Bioinformatics 22 (11), 1406-1407, 2006
An a posteriori error control framework for adaptive precision optimization using discontinuous Galerkin finite element method
J Lu
Massachusetts Institute of Technology, 2005
Higher-dimensional integration with Gaussian weight for applications in probabilistic design
J Lu, DL Darmofal
SIAM Journal on Scientific Computing 26 (2), 613-624, 2004
In vivo Polycomb kinetics and mitotic chromatin binding distinguish stem cells from differentiated cells
JP Fonseca, PA Steffen, S Müller, J Lu, A Sawicka, C Seiser, L Ringrose
Genes & development 26 (8), 857-871, 2012
Inverse bifurcation analysis: application to simple gene systems
J Lu, HW Engl, P Schuster
Algorithms for molecular biology 1, 1-16, 2006
Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens
J Lu, K Deng, X Zhang, G Liu, Y Guan
Iscience 24 (7), 2021
Quantitative systems pharmacology: a case for disease models
CJ Musante, S Ramanujan, BJ Schmidt, OG Ghobrial, J Lu, ...
Clinical Pharmacology & Therapeutics 101 (1), 24-27, 2017
An In-Silico Model of Lipoprotein Metabolism and Kinetics for the Evaluation of Targets and Biomarkers in the Reverse Cholesterol Transport Pathway
J Lu, K Hübner, MN Nanjee, EA Brinton, NA Mazer
PLoS computational biology 10 (3), e1003509, 2014
Deep learning prediction of patient response time course from early data via neural-pharmacokinetic/pharmacodynamic modelling
J Lu, B Bender, JY Jin, Y Guan
Nature machine intelligence 3 (8), 696-704, 2021
Trajectory enclosures for nonlinear systems with uncertain initial conditions and parameters
E August, J Lu, H Koeppl
2012 American Control Conference (ACC), 1488-1493, 2012
Multiscale mathematical model of drug-induced proximal tubule injury: linking urinary biomarkers to epithelial cell injury and renal dysfunction
Y Gebremichael, J Lu, H Shankaran, G Helmlinger, J Mettetal, KM Hallow
Toxicological Sciences 162 (1), 200-211, 2018
Computing the hazard ratios associated with explanatory variables using machine learning models of survival data
S Sundrani, J Lu
JCO Clinical Cancer Informatics 5, 364-378, 2021
An exact dual adjoint solution method for turbulent flows on unstructured grids
E Nielsen, J Lu, M Park, D Darmofal
41st Aerospace Sciences Meeting and Exhibit, 272, 2003
Evaluation of HDL-modulating interventions for cardiovascular risk reduction using a systems pharmacology approach
K Gadkar, J Lu, S Sahasranaman, J Davis, NA Mazer, S Ramanujan
Journal of lipid research 57 (1), 46-55, 2016
Polycation-mediated delivery of siRNAs for prophylaxis and treatment of influenza virus infection
M Thomas, Q Ge, JJ Lu, AM Klibanov, J Chen
Expert Opinion on Biological Therapy 5 (4), 495-505, 2005
Pharm‐AutoML: An open‐source, end‐to‐end automated machine learning package for clinical outcome prediction
G Liu, D Lu, J Lu
CPT: pharmacometrics & systems pharmacology 10 (5), 478-488, 2021
The system can't perform the operation now. Try again later.
Articles 1–20